QIV or TIV: Clinical Trials

1 completed. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Completed 1

Follow QIV or TIV: new trials by email Literature Review of QIV or TIV trials Research Report on QIV or TIV

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age aQIV or aTIV, QIV or TIV - Influenza, Human	Phase 3	Completed	Seqirus	38769	2023-10-23	2026-09-02

Conditions studied

Influenza, Human (1)

Sponsors

Seqirus (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Finland (1)  ·  Georgia (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Philippines (1)  ·  Poland (1)  ·  Romania (1)  ·  Serbia (1)  ·  South Africa (1)